客户文章

序号	作者	年份	标题	杂志	2022IF
1	Sun, L., et al.	2019	Fto Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice via Alterations in Gut Microbiota	Theranostics	12.4
2	Sun, L., et al.	2019	Fluoxetine ameliorates dysbiosis in a depression model induced by chronic unpredicted mild stress in mice	International Journal Of Medical Sciences	3.6
3	Lu, H. F., et al.	2019	Fecal Microbiome Data Distinguish Liver Recipients With Normal and Abnormal Liver Function From Healthy Controls	Frontiers in Microbiology	5.2
4	Ren, Z., et al.	2020	Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis	Small	13.3
5	Zhang, M.-L., et al.	2020	Citrobacter Species Increase Energy Harvest by Modulating Intestinal Microbiota in Fish: Nondominant Species Play Important Functions	mSystems	6.4
6	Lou, J., et al.	2020	Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals	Frontiers in Cellular and Infection Microbiology	5.7
7	Ren, Z., et al.	2020	Alterations of the Human Gut Microbiome in Chronic Kidney Disease	Advanced Science	15.1
8	Yu, W., et al.	2020	The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy	RENAL FAILURE	3.0
9	Dong, R., et al.	2020	A Comparative Study of the Gut Microbiota Associated with Immunoglobulin A Nephropathy and Membranous Nephropathy	Frontiers in Cellular and Infection Microbiology	5.7
10	Tang N., et al.	2020	The Association Between Gestational Diabetes and Microbiota in Placenta and Cord Blood	Frontiers in Endocrinology	5.2
11	Zhao, X., et al.	2020	The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes	Journal of Diabetes Research	4.3
12	Li, G.-H., et al.	2020	Response of gut microbiota to serum metabolome changes in intrahepatic cholestasis of pregnant patients	World Journal of Gastroenterology	4.3
13	Li, R., et al.	2021	The therapeutic efficacy of curcumin vs. metformin in modulating the gut microbiota in NAFLD rats: a comparative study	Frontiers in Microbiology	5.2
14	Ren Z., et al.	2021	Alterations in the human oral and gut microbiomes and lipidomics in COVID-19	Gut	24.5
15	Ding, J., et al.	2021	Gut microbial alteration in neonatal jaundice pre- and post-treatment	BIOSCIENCE REPORTS	4.0
16	Yang, X., et al.	2021	Effects of sepsis and its treatment measures on intestinal flora structure in critical care patients	World Journal of Gastroenterology	4.3
17	Lu, J., et al.	2021	Gut microbiota characterization in Chinese patients with alopecia areata	JOURNAL OF DERMATOLOGICAL SCIENCE	4.6
18	Rao, B., et al.	2021	Oral Microbiome Characteristics in Patients With Autoimmune Hepatitis	Frontiers in Cellular and Infection Microbiology	5.7
19	Gao, M., et al.	2021	Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients	Advanced Science	15.1
20	Liu, X., et al.	2021	Association between vaginal microbiota and risk of early pregnancy miscarriage	Comparative Immunology Microbiology and Infectious Diseases	2.0
21	Lu, H., et al.	2021	Lactitol Supplementation Modulates Intestinal Microbiome in Liver Cirrhotic Patients	Frontiers in Medicine	3.9
22	Lou, Y., et al.	2021	The composition of the lung microbiome differs between patients with dermatomyositis and rheumatoid arthritis associated with interstitial lung disease	FEBS Open Bio	2.6
23	Liu, K. X., et al.	2021	Biogeography of the Respiratory Tract Microbiome in Patients With Malignant Tracheal Tumors	Frontiers in Oncology	4.7
24	Du, Y., et al.	2021	Prevalence of Chronic Diseases and Alterations of Gut Microbiome in People of Ningxia China During Urbanization: An Epidemiological Survey	Frontiers in Cellular and Infection Microbiology	5.7
25	Xing, J. W., et al.	2021	919 syrup inhibits ROS-mediated leptin-induced anorexia by activating PPARγ and improves gut flora abnormalities	BIOMEDICINE & PHARMACOTHERAPY	7.5
27	Jiang, Q., et al.	2022	Mucosal bacterial dysbiosis in patients with nodular lymphoid hyperplasia in the terminal ileum	World Journal of Gastroenterology	4.3
28	Cui, G., et al.	2022	Gut Microbiome Distinguishes Patients With Epilepsy From Healthy Individuals	Frontiers in Microbiology	5.2
29	Tang, S., et al.	2022	Intermittent hypoxia is involved in gut microbial dysbiosis in type 2 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	World Journal of Gastroenterology	4.3
30	Ji, C., et al.	2022	Antibiotic treatments to mothers during the perinatal period leaving hidden trouble on infants	EUROPEAN JOURNAL OF PEDIATRICS	3.6
31	Cui, G., et al.	2022	Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up	Military Medical Research	21.1
32	Huang, C., et al.	2022	Oral Microbiota Profile in a Group of Anti-AChR Antibody–Positive Myasthenia Gravis Patients	Frontiers in Neurology	3.4
33	Yang, X., et al.	2022	Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis	Frontiers in Immunology	7.3
34	Huang, C., et al.	2022	Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17/Treg Cell Balance	Cells	6.0
35	Zhang, W., et al.	2022	Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus	Frontiers in Cellular and Infection Microbiology	5.7
36	Shang, J., et al.	2022	Gut Microbiome Analysis Can Be Used as a Noninvasive Diagnostic Tool and Plays an Essential Role in the Onset of Membranous Nephropathy	Advanced Science	15.1
37	Zhao, J., et al.	2022	Expansion of Escherichia-Shigella in Gut Is Associated with the Onset and Response to Immunosuppressive Therapy of IgA Nephropathy	Journal of the American Society of Nephrology	13.6
38	Bao, M., et al.	2022	Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients	Frontiers in Cellular and Infection Microbiology	5.7
39	Yan, J., et al.	2022	Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis	Frontiers in Immunology	7.3
40	Wang, X., et al.	2022	Serum metabolome alterations in patients with early nonalcoholic fatty liver disease	Bioscience Reports	4.0
41	Rao, B., et al.	2022	Alterations in the human oral microbiome in cholangiocarcinoma	Military Medical Research	21.1
42	Zhang, Y., et al.	2022	Characterization and diagnostic value of the gut microbial composition in patients with minimal change disease	Frontiers in Physiology	4.0
43	Dong, Y., et al.	2022	Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes	Frontiers in Cellular and Infection Microbiology	5.7
44	Wang, P., et al.	2022	Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice	Frontiers in Endocrinology	5.2
45	Shang, J., et al.	2022	The harmful intestinal microbial community accumulates during DKD exacerbation and microbiome–metabolome combined validation in a mouse model	Frontiers in Endocrinology	5.2
46	Cui, M., et al.	2022	The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota	BMC Microbiology	4.2
47	Tian, N., et al.	2023	Relationship between gut microbiota and nutritional status in patients on peritoneal dialysis	Scientific Reports	4.6
48	He, Y., et al.	2023	Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues	Journal of Translational Medicine	7.4
49	Guo, J., et al.	2023	Alterations in the human oral microbiota in systemic lupus erythematosus	Journal of Translational Medicine	7.4
50	Ma, X., et al.	2023	Distinguishable Influence of the Delivery Mode, Feeding Pattern, and Infant Sex on Dynamic Alterations in the Intestinal Microbiota in the First Year of Life	Microbial Ecology	3.6
51	Yang, X., et al.	2023	Exploring choices of early nutritional support for patients with sepsis based on changes in intestinal microecology	World Journal of Gastroenterology	4.3
52	Ren, Z., et al.	2023	Alterations of the oral and gut mycobiome and cytokines during long-term follow-up of COVID-19 convalescents	Signal Transduction and Targeted Therapy	39.3
53	Hu,X., et al.	2023	Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients	Advanced Science	15.1
54	Zou, Y., et al.	2023	Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites	Frontiers in Pharmacology	5.6
55	Zhao, M., et al.	2023	Characterization of Duodenal Microbiota in Patients with Acute Pancreatitis and Healthy Controls	Digestive Diseases and Sciences	3.1
56	Jiang, Y., et al.	2023	FG-4592 relieves diabetic kidney disease severity by influencing metabolic profiles via gut microbiota reconstruction in both human and mouse models	Frontiers in Physiology	4.0
57	Wang., L., et al.	2023	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	Frontiers in Endocrinology	5.2
58	Long., J., et al.	2023	Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora	Frontiers in Microbiology	5.2
59	Lian., X., et al.	2023	Oral microbiome alterations in epilepsy and after seizure control	Frontiers in Microbiology	5.2
60	Guo., S., et al.	2023	Association between gut microbial diversity and technique failure in peritoneal dialysis patients	Renal Failure	3
61	Lu., H., et al.	2023	Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial	Frontiers in Microbiology	5.2
62	Liang., C., et al.	2024	Altered ocular surface microbiota in obesity: a case-control study	Frontiers in Cellular and Infection Microbiology	5.7
63	Liu., Y., et al.	2024	Alteration in gut microbiota is associated with immune imbalance in Graves’ disease	Frontiers in Cellular and Infection Microbiology	5.7
64	Cui, G., et al.	2024	Dynamic changes of Bacterial Microbiomes in Oropharynx during Infection and Recovery of COVID-19 Omicron Variant	PLOS Pathogens	6.7
65	Cui., X., et al.	2024	Oral microbiome characteristics in patients with pediatric solid tumor	Frontiers in Microbiology	5.2